Frank Torti - 30 Jun 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jul 2026, 19:01:12 UTC
Prior SEC filing
09 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Richard Pulik, as Attorney-in-Fact for Frank Torti

Key filing fact

Frank Torti filed Form 4 for Roivant Sciences Ltd. (ROIV) on 02 Jul 2026.

Key facts

  • This page summarizes Frank Torti's Form 4 filing for Roivant Sciences Ltd. (ROIV).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jul 2026, 19:01.

Change

  • Previous filing in this sequence was filed on 09 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001647805 Primary reporting owner

Torti Frank

Relationship
President and Vant Chair
Address
C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM
Signature
By: /s/ Richard Pulik, as Attorney-in-Fact for Frank Torti
Signature date
02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Tax liability

Transaction value
Shares
-40,310
Change %
-0.3%
Price
$35.39*
Shares after
13,536,202
Date
30 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .